Kenya is actively seeking global investors to boost its local vaccine and medicine manufacturing capabilities, with Principal Secretary for Medical Services, Dr. Ouma Oluga, highlighting the nation's ambition to become Africa's leading hub in this sector. This initiative, championed by the Ministry of Health, aims to strengthen local capacity through flagship projects like the Kenya Biovax Institute, promising job creation and enhanced healthcare security for Africa.

• Dr. Ouma Oluga emphasized Kenya's commitment to partnering with investors to build a resilient healthcare ecosystem.
• Key organizations involved include Kenya Vision 2030, Dalberg, Blue Orange Capital, Health For Development, and the International Finance Corporation of the World Bank Group.
• The effort is expected to create jobs for young people and position Kenya as a continental leader in pharmaceutical innovation and supply security.